Brief: Seastar Medical Announces Pricing Of $9.0 Million Registered Direct Offering Priced At-The-Market
26/01/2024 16:49
Jan 26 (Reuters) - SeaStar Medical Holding Corp ICU.O :
* SEASTAR MEDICAL ANNOUNCES PRICING OF $9.0 MILLION
REGISTERED
DIRECT OFFERING PRICED AT-THE-MARKET
* SEASTAR MEDICAL: COMBINED EFFECTIVE OFFERING PRICE FOR
EACH
SHARE OF COMMON STOCK ACCOMPANYING SERIES A WARRANTS & SERIES B
WARRANTS IS $0.8302
Source text for Eikon: ID:nGNX7J1tV
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview